ACC.17

Patients were current statin users and had an LDL-C ≥70mg/dL, they were considered to have reached goal if they achieved an LDL-C level of less than 70mg/dL after 3 months of ezetimibe treatment.

While considered a standard treatment for atherosclerotic cardiovascular disease, the benefits of statins in patients with vasospastic angina were still an unknown.

At baseline, among 9722 patients with AF, frailty (defined by the American Geriatric Society Criteria) was identified in 5.9% of patients.

Treatment to prevent post-operative AF in patients undergoing cardiac surgery continues to be controversial.

The researchers searched the U.S. Medicare database for NVAF patients 65 years of age and older who were newly prescribed one of the following medications: apixaban, dabigatran, rivaroxaban, or warfarin.

There was a significant increase in ACS incidence within the 18-36 year old group.

The patient was brought to the emergency department (ED) after complaining of abdominal and chest pain that came on suddenly without exertion.

Study authors aimed to evaluate the association between beta-blocker use and all-cause mortality in patients presenting with ACS based on the presence or absence of significant LV dysfunction.

Previous studies involving statins have shown both men and women having similar risk reduction in cardiovascular disease events for every 39mg/dL reduction in LDL-C.